Radioimmunodetection of cancer: problems and potential.
- 12 November 1983
- Vol. 287 (6403) , 1402-1404
- https://doi.org/10.1136/bmj.287.6403.1402
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- TUMOUR LOCALISATION WITH MONOCLONAL ANTIBODY RADIOACTIVELY LABELLED WITH METAL CHELATE RATHER THAN IODINEThe Lancet, 1982
- Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen.BMJ, 1982
- TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURSThe Lancet, 1982
- LIPOSOMALLY ENTRAPPED SECOND ANTIBODY IMPROVES TUMOUR IMAGING WITH RADIOLABELLED (FIRST) ANTITUMOUR ANTIBODYThe Lancet, 1982
- Localization of I-131-Labeled Goat and Primate Anti-Carcinoembryonic Antigen (CEA) Antibodies in Patients with CancerInvestigative Radiology, 1982
- Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphyImmunology Today, 1981
- RADIOIMMUNOLOCALISATION OF TUMOURS BY EXTERNAL SCINTIGRAPHY AFTER ADMINISTRATION OF 131I ANTIBODY TO CARCINOEMBRYONIC ANTIGENNuclear Medicine Communications, 1980
- Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen.BMJ, 1980
- Tumor Location Detected with Radioactively Labeled Monoclonal Antibody and External ScintigraphyScience, 1979
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978